###### 

HCV RNA viral responses (Snapshot)

  Undetectable HCV RNA[\*](#TF0001_19626){ref-type="table-fn"} , n (%)   Treatment naïve (N=64)                Prior relapser (N=29)               Prior partial responder (N=18)              Prior null responder (N=51)               Overall (N=162)   
  ---------------------------------------------------------------------- ------------------------ ------------ ----------------------- ----------- -------------------------------- ---------- ----------------------------- ----------- ----------------- ------------
  Response by eRVR                                                                                                                                                                                                                                         
  Week 4 and 12 (eRVR)                                                   YES                      NO           YES                     NO          YES                              NO         YES                           NO          YES               NO
                                                                         37                       27           14                      15          10                               8          19                            32          80                82
  SVR12 planned (\<25 IU/mL)                                             31/37 (84)               10/27 (37)   13/14 (93)              5/15 (33)   10/10 (100)                      3/8 (38)   16/19 (84)                    5/32 (16)   70/80 (88)        23/82 (28)
  Response by planned treatment duration                                                                                                                                                                                                                   
  Planned treatment duration (weeks)                                     24                       48           24                      48          48                                          48                                        24 or 48          
  On-treatment virologic failure                                         2 (5)                    12 (44)      0                       1 (6)       5 (28)                                      21 (41)                                   41 (25)           
  Relapse                                                                2 (5)                    2 (7)        0                       1 (6)       0                                           3 (6)                                     8 (5)             
  SVR12 planned (\<25 IU/mL)                                             31/37 (84)               10/27 (37)   12/13 (92)              6/16 (38)   13 (72)                                     21 (41)                                   93 (57)           

HPS COBAS^®^ Taqman^®^ (v2.0, Roche): lower limit of quantification of 25IU/mL, limit of detection of 15IU/mL (genotype 1).
